These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1283095)

  • 1. Comparative purification of recombinant HIV-1 and HIV-2 reverse transcriptase: preparation of heterodimeric enzyme devoid of unprocessed gene product.
    Warren TC; Miglietta JJ; Shrutkowski A; Rose JM; Rogers SL; Lubbe K; Shih CK; Caviness GO; Ingraham R; Palladino DE
    Protein Expr Purif; 1992 Dec; 3(6):479-87. PubMed ID: 1283095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of heterodimeric human immunodeficiency virus type 1 (HIV-1) reverse transcriptase produced by in vitro processing of p66 with recombinant HIV-1 protease.
    Chattopadhyay D; Evans DB; Deibel MR; Vosters AF; Eckenrode FM; Einspahr HM; Hui JO; Tomasselli AG; Zurcher-Neely HA; Heinrikson RL
    J Biol Chem; 1992 Jul; 267(20):14227-32. PubMed ID: 1378437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of the human-immunodeficiency-virus-type-1 (HIV-1) reverse transcriptase gene to prevent dimerization of the expressed chimaeric protein: purification and characterization of a monomeric HIV-1 reverse transcriptase.
    Sharma SK; Basu A; Fan N; Evans DB
    Biotechnol Appl Biochem; 1994 Apr; 19(2):155-67. PubMed ID: 7514879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression, purification, and crystallisation of HIV-2 reverse transcriptase.
    Bird LE; Chamberlain PP; Stewart-Jones GB; Ren J; Stuart DI; Stammers DK
    Protein Expr Purif; 2003 Jan; 27(1):12-8. PubMed ID: 12509979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of microheterogeneity associated with recombinant HIV-1 heterodimeric reverse transcriptase.
    Chattopadhyay D; Einspahr HM; Brunner DP; Strakalaitis NA; Tarpley WG; Deibel MR
    Protein Expr Purif; 1992 Apr; 3(2):151-9. PubMed ID: 1384859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased yield of homogeneous HIV-1 reverse transcriptase (p66/p51) using a slow purification approach.
    Bhikhabhai R; Carlsson T; Unge T; Lövgren S; Strandberg B
    J Chromatogr; 1993 Jun; 639(1):67-74. PubMed ID: 7687250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of polypeptides of human immunodeficiency virus-1 reverse transcriptase in Escherichia coli.
    Becerra SP; Kumar A; Wilson SH
    Protein Expr Purif; 1993 Jun; 4(3):187-99. PubMed ID: 7686063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denaturation/refolding of purified recombinant HIV reverse transcriptase yields monomeric enzyme with high enzymatic activity.
    Deibel MR; McQuade TJ; Brunner DP; Tarpley WG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):329-40. PubMed ID: 1692723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 (HIV-1) recombinant reverse transcriptase. Asymmetry in p66 subunits of the p66/p66 homodimer.
    Sharma SK; Fan N; Evans DB
    FEBS Lett; 1994 Apr; 343(2):125-30. PubMed ID: 7513287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases.
    Fan N; Rank KB; Leone JW; Heinrikson RL; Bannow CA; Smith CW; Evans DB; Poppe SM; Tarpley WG; Rothrock DJ
    J Biol Chem; 1995 Jun; 270(22):13573-9. PubMed ID: 7539431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification, characterization and crystallization of recombinant HIV-1 reverse transcriptase.
    Bhikhabhai R; Joelson T; Unge T; Strandberg B; Carlsson T; Lövgren S
    J Chromatogr; 1992 Jun; 604(1):157-70. PubMed ID: 1379251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
    Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
    Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activity.
    Goobar-Larsson L; Bäckbro K; Unge T; Bhikhabhai R; Vrang L; Zhang H; Orvell C; Strandberg B; Oberg B
    Virology; 1993 Oct; 196(2):731-8. PubMed ID: 7690504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity.
    Hafkemeyer P; Ferrari E; Brecher J; Hübscher U
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5262-66. PubMed ID: 1711222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization.
    Taube R; Loya S; Avidan O; Perach M; Hizi A
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):579-87. PubMed ID: 9445385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reverse transcriptase of the human immunodeficiency virus: cloning, expression in Escherichia coli, purification of the enzyme, and production of monoclonal antibodies].
    Rechinskiĭ VO; Barbashov SF; Degtiarev IL; Vorob'ev SM; Liakhov DL; Kostiuk DA; Starov AI; Matsevich GR; Kochetkov SN
    Mol Biol (Mosk); 1991; 25(5):1248-57. PubMed ID: 1721676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of the reverse transcriptase enzyme from type 1 human immunodeficiency virus using different baculoviral vector systems.
    Pekrun K; Petry H; Jentsch KD; Moosmayer D; Hunsmann G; Lüke W
    Eur J Biochem; 1995 Dec; 234(3):811-8. PubMed ID: 8575439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
    Wakefield JK; Jablonski SA; Morrow CD
    J Virol; 1992 Nov; 66(11):6806-12. PubMed ID: 1383571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of a conserved residue within HIV-1 ribonuclease H affect its exo- and endonuclease activities.
    Wöhrl BM; Volkmann S; Moelling K
    J Mol Biol; 1991 Aug; 220(3):801-18. PubMed ID: 1714505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.
    Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK
    Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.